Literature DB >> 29127146

Cutting Edge: Processing of Oxidized Peptides in Macrophages Regulates T Cell Activation and Development of Autoimmune Arthritis.

Min Yang1, Claus Haase2, Johan Viljanen3, Bingze Xu1, Changrong Ge1, Jan Kihlberg3, Rikard Holmdahl4,5.   

Abstract

APCs are known to produce NADPH oxidase (NOX) 2-derived reactive oxygen species; however, whether and how NOX2-mediated oxidation affects redox-sensitive immunogenic peptides remains elusive. In this study, we investigated a major immunogenic peptide in glucose-6-phosphate isomerase (G6PI), a potential autoantigen in rheumatoid arthritis, which can form internal disulfide bonds. Ag presentation assays showed that presentation of this G6PI peptide was more efficient in NOX2-deficient (Ncf1m1J/m1J mutant) mice, compared with wild-type controls. IFN-γ-inducible lysosomal thiol reductase (GILT), which facilitates disulfide bond-containing Ag processing, was found to be upregulated in macrophages from Ncf1 mutant mice. Ncf1 mutant mice exhibited more severe G6PI peptide-induced arthritis, which was accompanied by the increased GILT expression in macrophages and enhanced Ag-specific T cell responses. Our results show that NOX2-dependent processing of the redox-sensitive autoantigens by APCs modify T cell activity and development of autoimmune arthritis.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29127146     DOI: 10.4049/jimmunol.1700774

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Inflammatory consequences of inherited disorders affecting neutrophil function.

Authors:  Mary C Dinauer
Journal:  Blood       Date:  2019-03-21       Impact factor: 22.113

Review 2.  B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature.

Authors:  Ozlem Pala; Alain Diaz; Bonnie B Blomberg; Daniela Frasca
Journal:  Clin Ther       Date:  2018-05-23       Impact factor: 3.393

Review 3.  Next-generation regulatory T cell therapy.

Authors:  Leonardo M R Ferreira; Yannick D Muller; Jeffrey A Bluestone; Qizhi Tang
Journal:  Nat Rev Drug Discov       Date:  2019-09-20       Impact factor: 84.694

4.  Regulatory T cells control epitope spreading in autoimmune arthritis independent of cytotoxic T-lymphocyte antigen-4.

Authors:  Min Yang; Katrin Klocke; Clara Marquina Hernandez; Bingze Xu; Inger Gjertsson; Kajsa Wing; Rikard Holmdahl
Journal:  Immunology       Date:  2018-07-31       Impact factor: 7.397

5.  Altered Humoral Immune Responses and IgG Subtypes in NOX2-Deficient Mice and Patients: A Key Role for NOX2 in Antigen-Presenting Cells.

Authors:  Julien Cachat; Christine Deffert; Marco Alessandrini; Pascale Roux-Lombard; Audrey Le Gouellec; Marie-José Stasia; Stéphanie Hugues; Karl-Heinz Krause
Journal:  Front Immunol       Date:  2018-07-11       Impact factor: 7.561

Review 6.  Reactive Oxygen Species in Autoimmune Cells: Function, Differentiation, and Metabolism.

Authors:  Weiji Lin; Pan Shen; Yaqin Song; Ying Huang; Shenghao Tu
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

7.  A non-immunological role for γ-interferon-inducible lysosomal thiol reductase (GILT) in osteoclastic bone resorption.

Authors:  Benjamin W Ewanchuk; Corey R Arnold; Dale R Balce; Priyatha Premnath; Tanis L Orsetti; Amy L Warren; Alexandra Olsen; Roman J Krawetz; Robin M Yates
Journal:  Sci Adv       Date:  2021-04-23       Impact factor: 14.136

Review 8.  Hydrogen sulfide: Recent progress and perspectives for the treatment of dermatological diseases.

Authors:  Mengting Xu; Lili Zhang; Shu Song; Lingling Pan; Ishfaq Muhammad Arslan; Yong Chen; Shengju Yang
Journal:  J Adv Res       Date:  2020-02-08       Impact factor: 10.479

Review 9.  Ferroptosis in Rheumatoid Arthritis: A Potential Therapeutic Strategy.

Authors:  Ting Zhao; Qi Yang; Yujiang Xi; Zhaohu Xie; Jiayan Shen; Zhenmin Li; Zhaofu Li; Dongdong Qin
Journal:  Front Immunol       Date:  2022-02-02       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.